BioBuzz: What is ATOM and why should people know about it?
Jim: It is a public–private consortium designed to improve the oncology drug discovery process by bringing together the expertise and resources of the FNLCR, the Lawrence Livermore National Laboratory (LLNL), GSK, and the University of California–San Francisco (UCSF).